Skip to main content
Image
Radcliffe Cardiology logo
Cardiology
Vascular CVRM Medical Education
Register for free Log in
Radcliffe Cardiology
Lifelong learning for cardiovascular healthcare professionals
Radcliffe Cardiology banner
Radcliffe Cardiology banner

Home

About

About Us

Topics

Featured Topics
Cardio-oncology
View AllAnticoagulationCOVID-19CV Disease in Special PopulationsDemographicDigital HealthElectrophysiology & ArrhythmiaHeart FailureInherited and Congenital Cardiac ConditionsImaging & DiagnosticsInterventionMI / ACSPericardium DisordersPrevention & Chronic ConditionsGuidelines & StatementsVascular Disease & Surgery

Content type

Videos Articles Journals Broadcasts Education Podcasts News

Faculty

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All
Juan Carlos KaskiPeter O'KaneAnkur KalraAngelo AuricchioHarriette Van SpallAndrew CoatsMirvat AlasnagArjun GhoshDemos KatritsisNicolas Van MieghemJoost DaemenCarolyn Lam

Events

Upcoming Events Radcliffe Events All Events

Resource Hubs

Deep Vein Thrombosis Empagliflozin in the Treatment of Chronic Heart Failure Hypertension Management Pulmonary Embolism Pulsed Field Ablation Sudden Cardiac Death The Bifurcation Center
  • Content for healthcare professionals only
Image
Radcliffe Cardiology logo
Register for free Log in
Back to Main Menu

View all platforms

Cardiology Vascular CVRM Medical Education
  • Content for healthcare professionals only

Breadcrumb

  • Home /
  • Authors /
  • Barry Borlaug
Barry Borlaug

Barry Borlaug

Mayo Clinic and Foundation, Rochester, MN, US

Expertise

Heart FailureHFpEF Pharmacological ManagementChronic Heart Failure ManagementInterventionCardiovascular Renal MetabolicHeart Failure ComorbiditiesHeart Failure and ObesityPrevention & Chronic ConditionsObesityGuidelines & StatementsElectrophysiology & ArrhythmiaMedication Optimisation and TitrationDigital HealthCardiovascular Co-MorbiditiesHeart Failure Services, Prevention and Digital HealthEquity, Age, Sex, and ReproductionHeart Failure in Women

Media

HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Video

Cardiovascular Renal Metabolic

Heart Failure

HFSA 25: Sex-specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
THT 2025: The SUMMIT Trial

Video

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic

THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s
ACC 23: Mechanism of Benefit for Dapagliflozin in HFpEF

Video

Heart Failure

ACC 23: Mechanism of Benefit for Dapagliflozin in HFpEF

Barry Borlaug

Watch time: 5m 21s

Video Series

Guidelines & Statements

Heart Failure

ACC 2023: Late-Breaking Science Video Collection

Enoch Akowuah, Annapoorna Kini , Atul Verma, et al

Watch time: 4h 22m 12s (29 videos)
Device Management in HFpEF and HFmrEF: Insights From the REDUCE LAP-HF II Trial

Video Series

Heart Failure

Intervention

Device Management in HFpEF and HFmrEF: Insights From the REDUCE LAP-HF II…

Barry Borlaug, Andrew JS Coats, Gerd Hasenfuß, et al

Watch time: 34m 37s (2 videos)
HFSA 2020: Primary HELP Trial Results - Dr Barry A Borlaug

Video

Heart Failure

HFSA 2020: Primary HELP Trial Results

Barry Borlaug

Watch time: 7m 58s
INDIE HFpEF Inorganic Nitrite Delivery

Video

Heart Failure

INDIE HFpEF Inorganic Nitrite Delivery to Improve Exercise Capacity in…

Barry Borlaug

Watch time: 4m 11s

Footer Menu 1

  • About Us
  • Our Team
  • Privacy
  • Terms & Conditions
  • Contact Us
  • Radcliffe Events
  • Radcliffe Group

Footer Menu 2

  • Authors A-Z
  • Image Gallery
  • Media Partners
  • Industry Partners
  • Services
  • Promotional Opportunities
  • Arrhythmia Academy
  • Education by Breas

Quick Links 1

  • Deep Vein Thrombosis
  • Empagliflozin in the Treatment of Chronic Heart Failure
  • Hypertension Management
  • The Bifurcation Center

Quick Links 2

  • Pulmonary Embolism
  • Sudden Cardiac Death
  • Pulsed Field Ablation
Register for FREE
Radcliffe Cardiology Logo

Copyright® 2026 Radcliffe Medical Media. All rights reserved.

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media.

Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.